randomised to receive a bolus dose of 15 ml, 0.25% bupivacaine followed by an infusion of
5–12 ml/h of 0.125% bupivacaine via lumbar epidural in EA group and a bolus dose of 0.4
ml/kg of 0.25% bupivacaine bilaterally via TAP catheter followed by continuous infusion at
5ml/h of 0.125% bupivacaine in TAP group postoperatively. VAS scores (primary objective)
and sensory dermatome blockade were recorded at 1, 4, 8, 12 and 24 h. Total morphine …